DevX Q1FY27: consolidated revenue slips 3% YoY, PAT thin at ₹1.5 Cr as finance costs rise
PAT +975.5% YoY · revenue -3.34% · margins expanding
₹53.77 Cr
-3.34% YoY
₹1.5 Cr
+975.5% YoY
2.65%
+2.4pp YoY
₹0.16
Dev Accelerator's (DevX) consolidated Q1 FY27 (quarter ended June 30, 2026) revenue came in at ₹53.77 Cr, down 3.3% YoY from ₹55.63 Cr and down 9.3% QoQ from ₹59.26 Cr in Q4 FY26. Consolidated PAT was ₹1.50 Cr (EPS ₹0.16) — up sharply YoY off a thin ₹0.14 Cr base a year ago, but down 81% QoQ from ₹7.96 Cr. There is no visible sell-side estimate for this print — analyst coverage is thin since the September 2025 IPO, and a web search on results day turned up no consensus figures — so vsStreet is unknown. Against management's own FY27 guidance from the May 2026 concall (revenue of ₹330-350 Cr and a steady 21-22% cash EBIT margin), the quarter is off to a weak start: a flat ₹53.77 Cr run-rate annualises to roughly ₹215 Cr, well short of the guided range, though this is only the first of four quarters against a full-year target.
Q1 FY-2027 vs prior quarters
The margin picture is split. Operating margin (revenue less operating, employee and other opex) actually expanded to 56.3% from 47.5% a year ago and 53.0% in Q4 FY26 (Q4's figure also absorbed a ₹1.15 Cr exceptional charge, absent this quarter), as core opex was contained even as revenue fell. But net margin stayed thin at 2.65% (versus 12.57% in Q4 and 0.25% a year ago) because Finance Costs rose to ₹14.0 Cr (+14% YoY, +36% QoQ) and Depreciation to ₹17.68 Cr (+22% YoY, +21% QoQ) — both consistent with the company capitalising new centres ahead of their revenue ramp, per its stated Tier-1/Tier-2 asset-commissioning plan. Standalone PAT of ₹2.00 Cr (on ₹41.98 Cr revenue) exceeded the consolidated ₹1.50 Cr, meaning subsidiaries/associates were a net drag this quarter.
The stock went into the print at ₹35, up 0.6% over the past month of trading.
Dev Accelerator Limited projects strong revenue growth for FY27, targeting INR330-350 crores, a significant increase from FY26. This growth will be driven by the commissioning of multiple new assets across Tier 1 and Tier 2 cities, building upon their successful asset-light development management model. Management anti
— This quarter: missed
During the quarter the company raised capital via a preferential allotment to Infibeam Projects Management and its promoters — 44.44 lakh equity shares (₹20.0 Cr) plus 33.33 lakh convertible warrants (₹15.0 Cr, of which ₹3.75 Cr/25% was received upfront) — taking paid-up capital to ₹18.93 Cr. Separately, it allotted ₹100 Cr of NCDs on August 4, 2026, whose finance-cost impact is explicitly excluded from this quarter's numbers as a non-adjusting subsequent event, and appointed Churchgate Advisory for IR services. No management press release or call commentary accompanied this filing, so the drivers above are inferred from the notes to the results rather than management's own framing.
W1
Full finance-cost impact of the ₹100 Cr NCD (allotted Aug 4, 2026, after quarter-end) hitting Q2 FY27 — Finance Costs were already ₹14.0 Cr this quarter before the NCD.
W2
Whether revenue re-accelerates toward management's ₹330-350 Cr FY27 target — Q1's ₹53.77 Cr implies only a ~₹215 Cr annualised run-rate.
W3
Exercise of the 33.33 lakh convertible warrants (₹15 Cr, 75%/₹11.25 Cr still receivable) within 18 months of the June 16, 2026 allotment.
Source figures in ₹ Lakh, converted to ₹ Cr; no exceptional items this quarter (Q4FY26 comparison qtr carried a ₹1.15 Cr exceptional charge); consolidated PAT ₹1.50 Cr (owners ₹1.48 Cr + NCI ₹0.02 Cr) trails standalone PAT ₹2.00 Cr on subsidiary/associate drag; standalone tax was a net credit of -₹0.58 Cr from deferred tax; no management press release accompanied this filing.
Signed pipeline grows to 2.3M sqft; Q1 revenue flat despite operational scale
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Hit occupancy/seat targets and enterprise mix shift. Missed revenue growth (flat YoY despite +31% seats). No FY27 guidance reaffirmation.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Strong operational metrics (31% seats, 92% occupancy, 70% enterprise mix, 2.63x rev/rent) and a large signed pipeline (2.31M sqft) support long-term growth. However, Q1 revenue was flat YoY (-3.3%) despite scale gains, and the FY27 guidance of ₹330–350 Cr appears likely to miss at the current ₹215 Cr run-rate. Noida closure cost ₹4.5 Cr quarterly, signalling execution risk. Management raised ₹100 Cr at 11.75% but also repaid ₹55 Cr; net leverage improved. Verdict: pipeline is real, but near-term revenue stalled and guidance credibility is at risk.
₹53.8 Cr
Revenue · −3.3% YoY₹1.5 Cr
Reported PAT · +975.3% YoYCompressing
Margins · vs guidance: OverstatedDid the claims hold up?
Enterprise clients 70% of revenue; occupancy up; Capital One operational
METEnterprise 70% (up from 52% YoY) confirmed. Occupancy 91.93% vs 88.6%. Capital One started end-FY26, only partial Q1 contribution.
Capital One generates ₹2.75–3 Cr monthly revenue at 95% pre-lease
MET₹2.75 Cr confirmed. Annualized ₹33 Cr = ₹1,044/sqft/year. First-year blended with 3–4 month rent-free/fit-out lag per management.
Revenue-to-rent ratio 2.63x; asset-light model working
Unverified2.63x stated. No independent verification in call. Lease liabilities ₹226 Cr (5–9 years) inflate balance sheet under Ind AS.
FY27 revenue growth targeting ₹330–350 Cr as guided in FY26 calls
OVERSTATEDQ1 only ₹53.8 Cr. Trajectory ₹215 Cr (×4) suggests miss on ₹330–350 Cr range. No reaffirmation this call.
Earnings quality
What changed since the last call
Enterprise client mix
Upgrade70% of Q1 revenue (up from 52% YoY). Sticky, high-margin segment. Demonstrates Tier-2 enterprise demand is real.
Noida operations
DowngradeNoida center closed mid-FY26 due to litigation. Lost ~₹4.5 Cr quarterly revenue post-closure. Three-center Noida portfolio now reduced to two; prior-year ₹11.5 Cr annual gone.
Capital structure
Upgrade₹100 Cr NCD raised at 11.75%; ₹55 Cr prior debt repaid. Net debt ₹81 Cr (from ₹89 Cr). But 1.85 Cr shares (19.65%) encumbered; promoter holding 36.81% (above 19.65% minimum).
Guidance
NeutralPrior FY27 target ₹330–350 Cr (from FY26 call) not reaffirmed or changed. Q1 trajectory ₹215 Cr annually suggests miss; management silent on revision.
The Q&A
Analysts pushed hard on Noida revenue discrepancies, Capital One yield vs Ahmedabad, and ROCE/leverage. Management initially evasive on Noida branch-level data, then corrected. Acknowledged lease-liability inflation and capex-to-revenue lag. Did not commit to updated guidance.
Noida center closure — Shubham Padhiyar, Chhattisgarh Investments
PartialNoida closure was end-of-year, so full FY26 was operational (~₹11.5 Cr annual). Remaining 2 centers grew occupancy/pricing. Post-closure, Q1 FY27 lost ₹4.5 Cr quarterly.
Capital One revenue yield — Shubham Padhiyar, Chhattisgarh Investments
AnsweredAhmedabad is ₹100–125/sqft/month = ₹1,200–1,500/year, not ₹2,500. Capital One first-year blended: 3–4 month rent-free/fit-out lag means 8–9 months of actual rent paid, depressing first-year yield to ₹87/sqft/month effective.
ROCE and true leverage — Mukul Bhushan, Raru Family Office
PartialCapex-to-revenue lag: centers take 6–9 months to mature. ₹1 capex may yield revenue next quarter/year. Lease liability is not borrowed money, no repayment schedule. Board advised investors look at borrowings separately.
Q4 margin decline — Mukul Bhushan, Raru Family Office
PartialOne-time expenses depressed Q4. Needle & Thread books per Ind AS milestone, not full revenue. Subsidiary margins lag. Industry peers at 60–65% EBITDA; we are 66% standalone, 59% consolidated.
Scalex Advisory JV and non-compete — Shubham Padhiyar, Chhattisgarh Investments
AnsweredScalex is 12% stake, JV with Savvy (real estate) and Talati & Talati (FP&A), only GIFT City focus. DevX still does GCC elsewhere. No conflict; Scalex redirects bundled GCC leads to Scalex only.
Guidance
FY27: ₹330–350 Cr (prior guidance, not reaffirmed)
LowQ1 only ₹53.8 Cr; trajectory ₹215 Cr annually. Guidance appears off-track unless signed pipeline converts much faster than history suggests.
Cash EBIT margin 21–22% (prior guidance from FY26 calls)
LowNot directly discussed this call. IGAAP EBITDA margin 23.2% vs 18.1% prior year. Standalone Ind AS 66% but consolidated 56.3% due to Needle & Thread accounting.
Ahmedabad phase-2: ~₹100 Cr capex planned; fits ₹200 Cr prior guidance
Medium9L sqft of 1.13M sqft operational built by DevX at ₹1,300/sqft. ~₹118 Cr invested to date. ₹100 Cr next phase. Timeline: FY27 H2 onwards.
Risks the call surfaced
Revenue conversion risk
High2.31M sqft signed but unproven conversion rate. Capital One (315k sqft) took 6+ months from signing to material revenue. FY27 guidance ₹330–350 Cr assumes faster ramp.
Center viability risk
MediumNoida center closed mid-FY26 due to litigation; ₹4.5 Cr quarterly revenue lost. Raises questions on legal/landlord risk across portfolio.
Leverage and debt service
Medium₹100 Cr NCD at 11.75% adds ₹11.75 Cr annual debt service. Lease liabilities ₹226 Cr (5–9 yr fixed) create real economic drag if occupancy/pricing reset. Net debt/equity 0.4x reported, but ~2.0x lease-inclusive.
Guidance credibility
HighFY27 revenue guidance ₹330–350 Cr (from FY26 calls) not reaffirmed this call. Q1 ₹53.8 Cr suggests full-year trajectory ~₹215 Cr (gap of ₹115–135 Cr = 33–41% miss).
Subsidiary drag
LowNeedle & Thread (design & build) ₹57 Cr in FY26 is project-based, booked per Ind AS milestone, not fully recurring. Inflates reported group numbers. SaaSJoy and Scalex are pre-revenue.
Management
Score 6/10. Mixed. Umesh clear on strategy and pipeline. Parin often evasive on financials, initially unclear on Noida, couldn't cite exact Ahmedabad revenue. Offered follow-up emails for missing data (Ahmedabad capex, branch-level numbers). Operational metrics (seats +31%, occupancy 92%, enterprise 70%) hit. Revenue growth stalled (−3.3% YoY). FY27 guidance ₹330–350 Cr appears off-track. Noida closure is a red flag.
1 · Q2 FY27 (Oct 2026)
Capital One full-quarter contribution; 0.19M sqft fit-out completions
2 · FY27 H2 (Jan–Mar 2027)
8.6L sqft Ahmedabad phase-2 handover; ₹100 Cr capex deployment starts
3 · FY28 (Apr 2027+)
1.4M sqft development-management pipeline matures; revenue ramp
Verdict: pipeline is real, but near-term revenue stalled and guidance credibility is at risk.
Pipeline Signed, Revenue Stalled
Q1 operational metrics shine: seats +31%, occupancy 92%, enterprise mix 70%. But consolidated revenue fell 3.3% YoY, and even standalone workspace revenue grew just 7.8%—signalling capacity ramp is outpacing pricing and fit-out. The signed pipeline of 2.31M sqft is compelling, but near-term execution risk has caught the market's attention: the stock is down 34.6% from its all-time high.
₹53.8 Cr
−3.3% YoY; includes Needle & Thread projects
₹42 Cr
+7.8% YoY; core workspace business
₹30.3 Cr
margin 56.3%, up from 47.4%; lease accounting inflation
91.93%
up from 88.6%; enterprise clients sticky
70%
up from 52% YoY; high-margin, sticky segment
2.31M sqft
across 40 centers; conversion timeline uncertain
The core tension of Q1 is one of operational scale masking execution lag. On the operating side, every metric points north: Dev Accelerator added 4,760 seats (31% growth), held occupancy at 92%, and pushed enterprise clients to 70% of revenue—a 18-point jump from the prior year that signals Tier-2 GCC demand is real and sticky. The signed pipeline of 2.31M sqft, priced at 2.63x revenue-to-rent, demonstrates real unit economics and market appetite. Yet consolidated revenue fell 3.3% YoY to ₹53.8 Cr, and even the core standalone workspace business grew just 7.8%—far below the seat growth rate. This signals that new capacity is ramping slower than headline numbers suggest: either Capital One (315k sqft) took longer to contribute than expected, or new centers are yielding below mature portfolio levels in their first year.
Where the revenue gap sits
Consolidated revenue of ₹53.8 Cr includes ₹11.8 Cr from Needle & Thread, the company's one-time design-and-build segment. In FY26, that business contributed ₹57 Cr; at the Q1 run-rate, it is headed for just ₹47 Cr annualized. Strip it out, and standalone workspace revenue is ₹42 Cr, up 7.8% YoY. Respectable in isolation—but against 31% seat growth, it flags a profitability headwind: new centers are more junior than the mature portfolio. Management cited ₹1,044/sqft/year for Capital One, versus ₹1,200–1,500/sqft for Ahmedabad—a first-year gap of ₹80–90/sqft/month that won't normalize until year 2, and reflects 3–4 months of fit-out and rent-free periods built into the economics.
Capital One first-year blended: 3–4 month rent-free/fit-out lag means 8–9 months of actual rent paid, depressing first-year yield to ₹87/sqft/month effective.
Enterprise clients 70% of revenue; occupancy up; Capital One operational
70% confirmed YoY (+18pts). Occupancy 91.93% vs 88.6% (+3.3pts). Capital One started end-FY26; Q1 only partial contribution.
Supported
Capital One generates ₹2.75–3 Cr monthly revenue at 95% pre-lease
₹2.75 Cr confirmed. Annualized ₹33 Cr = ₹1,044/sqft/year. First-year yield depressed by fit-out lag; normalizes year 2.
Supported (with caveat)
Revenue-to-rent ratio 2.63x; asset-light model working
2.63x stated by management. No independent verification in call. Lease liabilities ₹226 Cr (5–9 yr) inflate balance sheet under Ind AS.
Unverified
FY27 revenue growth targeting ₹330–350 Cr as guided in FY26 calls
Q1 only ₹53.8 Cr. Annualized trajectory ₹215 Cr. No reaffirmation this call. Guidance appears 33–41% off-track.
Overstated
What changed on this call
Enterprise mix jumped 18 points to 70%, a material upgrade. Sticky, high-margin clients (Tier-2 GCCs) now dominate revenue. Validates the strategy shift from pure flex-space to managed-office-for-enterprises.
Noida operations closed mid-FY26 due to litigation. Cost: ₹4.5 Cr quarterly revenue post-closure (₹11.5 Cr annual pre-closure). The three-center Noida portfolio is now two-center. This is a red flag: execution and landlord risk can upend even a signed asset.
Capital structure improved: ₹100 Cr NCD raised at 11.75%; ₹55 Cr existing debt repaid. Net debt ₹81 Cr (from ₹89 Cr). But ₹11.75 Cr annual coupon is a new fixed cost, and 1.85 Cr shares (19.65%) are encumbered; promoter holding 36.81% (above minimum).
Guidance was not reaffirmed or updated. FY27 ₹330–350 Cr target (from FY26 calls) remains on the table, but Q1 ₹53.8 Cr suggests annualized ₹215 Cr (gap of ₹115–135 Cr, or 33–41%). Management's silence on this revision is notable.
1.13M sqft operational, 92% occupied—platform is real
Enterprise mix now 70%, up 18pts—sticky, high-margin clients driving mix
Signed pipeline 2.31M sqft at 2.63x rev/rent—unit economics strong
Development-management model reduces land acquisition risk
Standalone revenue +7.8% YoY—respectable, but weak vs +31% seat growth
Capital One first-year yield ₹1,044/sqft (vs mature ₹1,200–1,500/sqft)—new-center drag
Noida closure cost ₹4.5 Cr quarterly—execution/litigation risk is material
FY27 guidance ₹330–350 Cr not reaffirmed; ₹215 Cr run-rate implies 33–41% miss
₹226 Cr lease liabilities (5–9 yr fixed)—real fixed-cost drag if occupancy resets
Needle & Thread one-time revenue down from ₹57 Cr FY26 to ₹11.8 Cr Q1 run-rate
How the street is positioned
The market has delivered a clear verdict: the stock is down 34.6% from its all-time high of ₹50.28, now trading at ₹32.88. It sits below all major moving averages (SMA20 ₹34.08, SMA50 ₹34.96, SMA200 ₹39.08), signalling a downtrend. The Q1 result reaction was swift: −2.71% on day 1, −6.06% by day 3. The market is not treating this as a base-building opportunity, but as confirmation of execution risk.
Institutional flows are trimming. FII ownership fell from 1.43% (Q4 FY26) to 1.36% (Q1 FY27)—a small outflow but directional. DII also trimmed, from 4.94% to 3.93% (−101 basis points). Promoter holding fell from 36.81% to 35.09% (−172 basis points), suggesting even insiders are lightening. The composite picture: institutions and promoters are both exiting, not rotating into a dip. This is the market pricing in guidance miss risk, not a buying opportunity.
Risks, ranked by how much they should concern a holder
Guidance miss on FY27 revenue (₹330–350 Cr target)
HighQ1 ₹215 Cr run-rate suggests ₹115–135 Cr shortfall (33–41%). If guidance misses, stock likely down further. Market already priced for caution (down 34.6% from ATH).
Signed pipeline conversion rate slower than needed
High2.31M sqft needs to convert at ₹40+ Cr annual run-rate to close the gap. Capital One took 6+ months to ramp; Ahmedabad phase-2 is mid-FY27 handover. If ramp delays into FY28, near-term earnings are structurally lower.
Center viability and litigation
MediumNoida closure due to litigation is precedent. Raises questions on legal/landlord risk across 27-city portfolio. Even a single center closure costs ₹4–5 Cr quarterly.
Lease liabilities and fixed-cost burden
Medium₹226 Cr lease liabilities (5–9 yr fixed) inflate balance sheet and are a real economic drag. If occupancy or pricing resets, margin compression is likely.
New-center yield depression
MediumCapital One yields ₹1,044/sqft vs mature ₹1,200–1,500/sqft. If all new centers are similarly depressed in year 1, revenue growth lags seat growth for 18–24 months.
1 · Q2 FY27 earnings (October 2026)
Capital One full-quarter contribution and occupancy trajectory. If standalone revenue still grows below 15% YoY, the ramp thesis is in trouble and guidance miss is confirmed.
2 · Ahmedabad phase-2 handover and ₹100 Cr capex deployment
Scheduled FY27 H2 (Jan–Mar 2027). If delayed, the FY27 revenue gap widens. Management has acknowledged 'execution risk' as capacity becomes operational.
3 · Guidance revision or reaffirmation
In Q2 earnings or H1 close, does management reaffirm ₹330–350 Cr FY27 target, or walk it down? A silent miss signals governance concern.
This quarter is a study in operational execution vs. near-term revenue delivery. The platform—1.13M sqft, 92% occupied, 70% enterprise—is real and scalable. The signed pipeline (2.31M sqft) and unit economics (2.63x rev/rent) are compelling. But Q1 revenue stalled (−3.3% YoY) despite +31% seat growth, and the FY27 guidance of ₹330–350 Cr appears 33–41% off-track at the current ₹215 Cr run-rate.
The market has priced in this execution risk: the stock is down 34.6% from its all-time high, trading below all major moving averages, with institutions and promoters trimming. The bull case—that Capital One ramps faster in Q2 and Ahmedabad phase-2 closes the gap in H2—is plausible but requires faster conversion than history suggests.
The single number to track: FY27 full-year consolidated revenue. If it lands above ₹280 Cr, the pipeline is converting and the near-term stall was temporary. If it lands below ₹250 Cr, the guidance miss is confirmed and the downtrend likely persists. Until Q2 earnings prove the ramp is accelerating, the stock is a hold.